MCRB Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Development Activities OEC Q1 2026 Earnings Significant EPS Miss Amid Positive Stock Reaction FITBI Q1 2026 Earnings EPS Surges Past Estimates Modest Stock Response NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist Mexco Energy MXC Jumps 428 Key Levels to Watch as Energy Stocks Gain Rumble Inc Warrants RUMBW Surge 417 as Price Nears Resistance at 21 Terns Pharmaceuticals TERN Steadies Near Support Amid Flat Trading Session Veracyte Shares Dip as Biotech Sector Faces Headwinds Key Support Tested WES Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency